GlennMorrisMillsMDFACP

Hematology • Shreveport, LA

Clotting Disorder, Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias

Professor Of Medicine, LSUHSC Shreveport Emeritus Director of the Feist-Weiller Cancer Center Shreveport

Join to view full profile

Dr. Mills is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mills' full profile

Already have an account?

Office
1501 Kings Hwy
Department Of Medicine
Shreveport, LA 71103
Phone+1 318-813-1061

Summary

Dr. Glenn Mills is an oncologist in Shreveport, LA and is affiliated with multiple hospitals in the area, including Ochsner LSU Health Shreveport - Monroe Medical Center, Ochsner LSU Health Shreveport - Academic Medical Center, and Overton Brooks Veterans Affairs Medical Center. He received his medical degree from University of Mississippi School of Medicine and has been in practice 43 years. He specializes in head & neck cancer, hematologic oncology, and thoracic cancer and is experienced in squamous cell carcinoma, amyloidosis, hematologic oncology, myelodysplasia, and myelofibrosis.

Education & Training

San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1978 - 1980
Tripler Army Medical CenterResidency, Internal Medicine, 1975 - 1978
University of Mississippi School of MedicineClass of 1974

Certifications & Licensure

LA State Medical License 1986 - 2025
MS State Medical License 1975 - 2025
TX State Medical License 1980 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Clinical Trials

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers Start of enrollment: 2006 Apr 01
Completed
L-Arginine Supplements in Treating Women Who Are Cancer Survivors Start of enrollment: 2007 May 01
Completed
Not Applicable
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer Start of enrollment: 2008 Jan 01
Terminated
Phase 1
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
Completed
Phase 2
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
Completed
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Start of enrollment: 2010 Mar 01
Terminated
Phase 3
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2010 Feb 01
Terminated
Phase 3
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Completed
Phase 3
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer Start of enrollment: 2010 Dec 01
Completed
Phase 2
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer Start of enrollment: 2011 Jan 01
Terminated
Phase 3
S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy Start of enrollment: 2011 Aug 09
Active, not recruiting
Phase 2
S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy Start of enrollment: 2012 Feb 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

31 citations
Outcomes-based evaluation in resident education: creating systems and structured portfolios.
Eric S. Holmboe, William Rodak, Glenn Mills, Michael J. McFarlane, Henry J. Schultz
The American Journal of Medicine. 2006-08-01
27 citations
Insurance Status and Other Non-biological Factors Predict Outcomes in Acute Myelogenous Leukemia: Analysis of Data from the National Cancer Database
Samip Master, Reinhold Munker, Zhenzhen Shi, Glenn Mills, Runhua Shi
Anticancer Research. 2016-09-01
37 citations
Docetaxel, cisplatin and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients wit...
David J. Adelstein, James J. Moon, Ehab Y. Hanna, P. G. Shankar Giri, Glenn Mills
Head & Neck. 2009-06-25

Authored Content

Longevity After Radiotherapy of Stage III Lung Cancer: Superior Vena Cava Obstruction Is Associated with Early MortalityApril 2018

Press Mentions

Maine Lost 1,200 Jobs Last Month as Virus Cases Slowed RecoverySeptember 17th, 2021
In BusinessMarch 12th, 2017

Grant Support

Lsuhsc-Shreveport Feist-Weiller Cancer Center MbccopNational Cancer Institute2007–2011
Southwest Oncology GroupNational Cancer Institute1995–2003
Southwest Oncology GroupNational Cancer Institute1986

Professional Memberships

American Society of Clinical Oncology - ASCO
Member